Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Duclos

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
Therapeutic equivalence of single oral doses of dolasetron mesilate and multiple doses of ondansetron for the prevention of emesis after moderately emetogenic chemotherapy. European Dolasetron Comparative Study GroupA A Fauser, B Duclos, A Chemaissani, et al.
European Journal of Gynaecological Oncology|January 1, 1991
High dose melphalan and ABMT with or without abdominal radiotherapy as consolidation treatment for ovarian carcinoma in complete remission or with microscopic residual diseaseP Dufour, J P Bergerat, K L Liu, et al.
Leukemia|February 3, 1998
Association between myelodysplastic syndromes and inflammatory bowel diseases. Report of seven new cases and review of the literatureM Hebbar, D Kozlowski, E Wattel, et al.
International Journal of Cancer|February 10, 1998
Inactivation of p53 in normal human cells increases G2/M arrest and sensitivity to DNA-damaging agentsJ Céraline, G Deplanque, B Duclos, et al.
Gynecologic Oncology|October 29, 1998
Paclitaxel-anthracycline combination chemotherapy in relapsing advanced ovarian cancer after platinum-based chemotherapy: a pilot studyJ E Kurtz, G Deplanque, B Duclos, et al.
Oncogene|September 19, 2012
Regulation of the tumor suppressor homeogene Cdx2 by HNF4α in intestinal cancerT Saandi, F Baraille, L Derbal-Wolfrom, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 15, 2011
[Case report of kidney cancer from JOUM 2010]Y Neuzillet, L Guy, J-A Long, et al.
Bulletin Du Cancer|July 1, 1996
[Carboplatin and cyclophosphamide in stage Ic-IV ovarian carcinoma: retrospective study of 101 cases]T Petit, P Dufour, J C Barrats, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1996
5-Fluorouracil versus 5-fluorouracil plus alpha-interferon as treatment of metastatic colorectal carcinoma. A randomized studyP Dufour, F Husseini, B Dreyfus, et al.
Gut|May 17, 2007
Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprineG Vernier-Massouille, J Cosnes, M Lemann, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
Therapeutic equivalence of single oral doses of dolasetron mesilate and multiple doses of ondansetron for the prevention of emesis after moderately emetogenic chemotherapy. European Dolasetron Comparative Study GroupA A Fauser, B Duclos, A Chemaissani, et al.
European Journal of Gynaecological Oncology|January 1, 1991
High dose melphalan and ABMT with or without abdominal radiotherapy as consolidation treatment for ovarian carcinoma in complete remission or with microscopic residual diseaseP Dufour, J P Bergerat, K L Liu, et al.
Leukemia|February 3, 1998
Association between myelodysplastic syndromes and inflammatory bowel diseases. Report of seven new cases and review of the literatureM Hebbar, D Kozlowski, E Wattel, et al.
International Journal of Cancer|February 10, 1998
Inactivation of p53 in normal human cells increases G2/M arrest and sensitivity to DNA-damaging agentsJ Céraline, G Deplanque, B Duclos, et al.
Gynecologic Oncology|October 29, 1998
Paclitaxel-anthracycline combination chemotherapy in relapsing advanced ovarian cancer after platinum-based chemotherapy: a pilot studyJ E Kurtz, G Deplanque, B Duclos, et al.
Oncogene|September 19, 2012
Regulation of the tumor suppressor homeogene Cdx2 by HNF4α in intestinal cancerT Saandi, F Baraille, L Derbal-Wolfrom, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 15, 2011
[Case report of kidney cancer from JOUM 2010]Y Neuzillet, L Guy, J-A Long, et al.
Bulletin Du Cancer|July 1, 1996
[Carboplatin and cyclophosphamide in stage Ic-IV ovarian carcinoma: retrospective study of 101 cases]T Petit, P Dufour, J C Barrats, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1996
5-Fluorouracil versus 5-fluorouracil plus alpha-interferon as treatment of metastatic colorectal carcinoma. A randomized studyP Dufour, F Husseini, B Dreyfus, et al.
Gut|May 17, 2007
Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprineG Vernier-Massouille, J Cosnes, M Lemann, et al.
Pageof 13